Found 28 matching trials
Preoperative Chemoradiotherapy for Locally Advanced Resectable Gastric Adenocarcinoma
PHASE2Gastric cancer is a high incidence in Asia, and one of the leading cause of...
Location
Severance Hospital, Yonsei University Health System
A Study of TS-1, Cisplatin (CDDP) and RAD001 (Everolimus)
PHASE1Hypothesis: The addition of RAD001 to TS-1/CDDP is safe and can improved th...
Location
National University Hospital
Cetuximab in Combination With S-1 and Cisplatin in Gastric Cancer
PHASE2This open-label, single-arm, multicenter, Phase 2 trial will treat at least...
Location
Please contact the Merck KGaA Communication Center located in
S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer
PHASE3A multicenter, randomized, open-label, phase III trial of S-1 plus cisplati...
Location
Seoul National University Bundang Hospital
Postoperative Chemoradiotherapy With S-1 in Gastric Cancer
PHASE2This study was conducted to evaluate the clinical outcomes and toxicities o...
Location
Chonnam National University Hwasun Hospital
Cisplatin Combined with Oral TS-1 in Patients with Advanced Solid Tumors with Different Degrees of Liver Dysfunction
PHASE2The purpose of this study is to formally characterize the pharmacokinetics ...
Status
Active Not Recruiting
Location
National University Hospital
Cisplatin,Docetaxel and S-1 for Advanced Gastric and Gastroesophageal Junction Cancer
PHASE2The combination of Cisplatin and S-1 (CS) achieved a response rate of appro...
Location
Cancer Hospital & Institute, Chinese Academy of Medical Sciences
S-1, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIA, Stage III, or Stage IVA Esophageal Cancer That Can Be Removed by Surgery
PHASE2RATIONALE: Drugs used in chemotherapy, such as S-1 and cisplatin, work in d...
Location
Yonsei Cancer Center at Yonsei University Medical Center
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
PHASE3The aim of this study is to evaluate survival benefit of TS-1 plus cisplati...
Location
Aichi Cancer Center Hospital
A Study of TS-1 Plus Irinotecan and Cisplatin (IP) for Patients With Stage IIIB/IV Non Small Cell Lung Cancer (NSCLC)
PHASE1The irinotecan and cisplatin combination showed significant anti-tumor acti...
Location
Asan Medical Center